| 1 |
Tang W, Du M, Zhang S, Jiang H. Sitagliptin attenuates Porphyromonas gingivalis virulence and inflammatory response in macrophage on titanium. Arch Oral Biol 2023;149:105659. [PMID: 36871330 DOI: 10.1016/j.archoralbio.2023.105659] [Reference Citation Analysis]
|
| 2 |
Siwicki M, Kubes P. Neutrophils in host defense, healing, and hypersensitivity: Dynamic cells within a dynamic host. J Allergy Clin Immunol 2023;151:634-55. [PMID: 36642653 DOI: 10.1016/j.jaci.2022.12.004] [Reference Citation Analysis]
|
| 3 |
Gui Y, He X, Yu J, Jing J. Artificial Intelligence-Assisted Transcriptomic Analysis to Advance Cancer Immunotherapy. J Clin Med 2023;12. [PMID: 36835813 DOI: 10.3390/jcm12041279] [Reference Citation Analysis]
|
| 4 |
Lugani S, Halabi EA, Oh J, Kohler RH, Peterson HM, Breakefield XO, Chiocca EAA, Miller MA, Garris CS, Weissleder R. Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti-Tumor Immunity in Murine Glioblastoma. Adv Mater 2023;35:e2208782. [PMID: 36427266 DOI: 10.1002/adma.202208782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Pfefferlé M, Dubach IL, Buzzi RM, Dürst E, Schulthess-Lutz N, Baselgia L, Hansen K, Imhof L, Koernig S, Le Roy D, Roger T, Humar R, Schaer DJ, Vallelian F. Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity. J Immunother Cancer 2023;11. [PMID: 36593065 DOI: 10.1136/jitc-2022-005718] [Reference Citation Analysis]
|
| 6 |
Coukos A, Vionnet J, Obeid M, Bouchaab H, Peters S, Latifyan S, Wicky A, Michielin O, Chtioui H, Moradpour D, Fasquelle F, Sempoux C, Fraga M. Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events. J Immunother Cancer 2022;10. [PMID: 36283734 DOI: 10.1136/jitc-2022-005635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Lang I, Zaitseva O, Wajant H. FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies. IJMS 2022;23:12869. [DOI: 10.3390/ijms232112869] [Reference Citation Analysis]
|
| 8 |
Murgaski A, Kiss M, Van Damme H, Kancheva D, Vanmeerbeek I, Keirsse J, Hadadi E, Brughmans J, Arnouk SM, Hamouda AEI, Debraekeleer A, Bosteels V, Elkrim Y, Boon L, Hoves S, Vandamme N, Deschoemaeker S, Janssens S, Garg AD, Vande Velde G, Schmittnaegel M, Ries CH, Laoui D. Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages. Cancer Res 2022;82:3785-801. [PMID: 35979635 DOI: 10.1158/0008-5472.CAN-22-0094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Khurana A, Navik U, Allawadhi P, Yadav P, Weiskirchen R. Spotlight on liver macrophages for halting liver disease progression and injury. Expert Opin Ther Targets 2022. [PMID: 36202756 DOI: 10.1080/14728222.2022.2133699] [Reference Citation Analysis]
|
| 10 |
Dai Z, Fu J, Peng X, Tang D, Song J. Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy. Cancers (Basel) 2022;14:4796. [PMID: 36230724 DOI: 10.3390/cancers14194796] [Reference Citation Analysis]
|
| 11 |
Guilliams M, Scott CL. Liver macrophages in health and disease. Immunity 2022;55:1515-29. [PMID: 36103850 DOI: 10.1016/j.immuni.2022.08.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 12 |
Zheng Z, Xu Y, Shi Y, Shao C. Neutrophils in the tumor microenvironment and their functional modulation by mesenchymal stromal cells. Cellular Immunology 2022;379:104576. [DOI: 10.1016/j.cellimm.2022.104576] [Reference Citation Analysis]
|
| 13 |
Lasagna A, Lenti MV, Cassaniti I, Sacchi P. Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report. Immunotherapy 2022;14:915-25. [PMID: 35694999 DOI: 10.2217/imt-2021-0342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 14 |
Hu X, Zhou X. Impact of single-cell RNA sequencing on understanding immune regulation. J Cell Mol Med 2022. [PMID: 35906816 DOI: 10.1111/jcmm.17493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Salomon R, Dahan R. Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy. Front Immunol 2022;13:940674. [DOI: 10.3389/fimmu.2022.940674] [Reference Citation Analysis]
|
| 16 |
Issa M, Tang J, Guo Y, Coss C, Mace TA, Bischof J, Phelps M, Presley CJ, Owen DH. Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer. Expert Rev Anticancer Ther 2022;:1-14. [PMID: 35786142 DOI: 10.1080/14737140.2022.2094772] [Reference Citation Analysis]
|
| 17 |
Li W, Chang N, Li L. Heterogeneity and Function of Kupffer Cells in Liver Injury. Front Immunol 2022;13:940867. [DOI: 10.3389/fimmu.2022.940867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Ngo W, Ahmed S, Blackadar C, Bussin B, Ji Q, Mladjenovic SM, Sepahi Z, Chan WCW. Why nanoparticles prefer liver macrophage cell uptake in vivo. Adv Drug Deliv Rev 2022;185:114238. [PMID: 35367524 DOI: 10.1016/j.addr.2022.114238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Oswalt CJ, Al-Rohil RN, Theivanthiran B, Haykal T, Salama AKS, DeVito NC, Holtzhausen A, Ko DC, Hanks BA. Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events. J Immunother 2022. [PMID: 35621992 DOI: 10.1097/CJI.0000000000000425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Quail DF, Amulic B, Aziz M, Barnes BJ, Eruslanov E, Fridlender ZG, Goodridge HS, Granot Z, Hidalgo A, Huttenlocher A, Kaplan MJ, Malanchi I, Merghoub T, Meylan E, Mittal V, Pittet MJ, Rubio-Ponce A, Udalova IA, van den Berg TK, Wagner DD, Wang P, Zychlinsky A, de Visser KE, Egeblad M, Kubes P. Neutrophil phenotypes and functions in cancer: A consensus statement. J Exp Med 2022;219. [PMID: 35522219 DOI: 10.1084/jem.20220011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 39.0] [Reference Citation Analysis]
|
| 21 |
Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol 2022. [PMID: 35354979 DOI: 10.1038/s41571-022-00620-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 22 |
Salomon R, Rotem H, Katzenelenbogen Y, Weiner A, Cohen Saban N, Feferman T, Amit I, Dahan R. Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting. Nat Cancer 2022;3:287-302. [PMID: 35190724 DOI: 10.1038/s43018-022-00329-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 23 |
Murgaski A, Kiss M, Van Damme H, Kancheva D, Vanmeerbeek I, Keirsse J, Hadadi E, Brughmans J, Arnouk SM, Hamouda AEI, Debraekeleer A, Bosteels V, Elkrim Y, Boon L, Hoves S, Vandamme N, Deschoemaeker S, Janssens S, Garg AD, Schmittnägel M, Ries CH, Laoui D. Distinct cDC subsets co-operate in CD40 agonist response while suppressive microenvironments and lack of antigens subvert efficacy.. [DOI: 10.1101/2021.12.25.474021] [Reference Citation Analysis]
|
| 24 |
Blake SJ, James J, Ryan FJ, Caparros-Martin J, Eden GL, Tee YC, Salamon JR, Benson SC, Tumes DJ, Sribnaia A, Stevens NE, Finnie JW, Kobayashi H, White DL, Wesselingh SL, O'Gara F, Lynn MA, Lynn DJ. The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota. Cell Rep Med 2021;2:100464. [PMID: 35028606 DOI: 10.1016/j.xcrm.2021.100464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Karin N. Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones? Cancers (Basel) 2021;13:6317. [PMID: 34944943 DOI: 10.3390/cancers13246317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 26 |
Siwicki M, Pittet MJ. Versatile neutrophil functions in cancer. Semin Immunol 2021;:101538. [PMID: 34876331 DOI: 10.1016/j.smim.2021.101538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 27 |
Hindson J. Liver macrophages and neutrophils in immunotherapy-related toxicity. Nat Rev Gastroenterol Hepatol 2021;18:593. [PMID: 34316058 DOI: 10.1038/s41575-021-00507-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
